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Abstract
Introduction
The study analyzes the effect of an advanced access pro-
gram on quality of diabetes care.
Methods
We conducted this study in a medical group of 240,000 
members served by 17 primary care clinics. Seven thou-
sand adult patients older than 18 years of age with dia-
betes were identified from administrative databases. Two 
aspects of advanced access — wait time for appointments 
and continuity of care — were calculated yearly for each 
patient  during  1999  through  2001.  We  developed  three 
composite measures of glucose and lipid control — pro-
cess (proportion of patients with appropriate testing rates 
of  hemoglobin  A1c  [HbA1c]  and  low-density  lipoprotein 
[LDL]),  good  control  (proportion  with  HbA1c  <  8%  and 
LDL < 130 mg/dL) and excellent control (proportion with 
HbA1c < 7% and LDL < 100 mg/dL) — and assessed them 
each  year  for  each  patient.  We  used  multilevel  logistic 
regression to predict the measures in 2000 and 2001 (years 
during and after advanced access implementation) rela-
tive to 1999 (year pre-advanced access).
Results
After  implementation  of  advanced  access,  wait  time 
decreased  from  21.6  days  to  4.2  days,  and  continuity 
improved by 6.5% (both P < .01). The percentage of patients 
with HbA1c < 7% increased from 44.4% to 52.3% and with 
LDL < 100 mg/dL from 29.8% to 38.7%. Increased continu-
ity predicted improved process (P = .01), good control (P = 
.033), and excellent control (P < .001). However, wait time 
did not significantly predict process (P = .62) or quality 
measures (P = .95).
Conclusion
Measures of the quality of diabetes control improved in 
the year after implementation of advanced access, but bet-
ter care did not correlate with decreased wait time to see a 
provider. However, improved continuity of care predicted 
improvements  in  both  process  and  quality  of  diabetes 
care.
Introduction
In 2001, the Institute of Medicine highlighted serious 
deficits in the quality of medical care in the United States 
(1). Timeliness (“reducing waits and sometimes harmful 
delays”) was one of six domains of quality cited as having 
a wide gap between “the care we have and the care we 
could have.”
To bridge this gap, many medical groups are considering 
ways of implementing programs to increase the availability 
of appointments with primary care physicians. The “open 
access” approach — creating walk-in clinics or holding the 
schedules of one or more designated physicians on a given 
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day or week for same-day care — can decrease wait time 
(defined as length of wait in days until the next available 
appointment), but it does not necessarily improve continu-
ity of care because patients often see doctors other than 
their own (2,3). Another approach — advanced access (4,5) 
— encourages providers to see their own patients on the 
day a patient requests a visit, thus improving continuity of 
care (6). The benefits of advanced access on appointment 
availability have been reported (7).
We aimed to determine whether implementation of ad-
vanced  access  affected  composite  measures  of  diabetes 
care. Specifically, we explored the effect of the improved 
availability  of  appointments  and  continuity  resulting 
from  advanced  access  on  quality  measures  of  care  for 
patients with diabetes. Ours is the first report of the effect 
of advanced access on the quality of care of patients with 
a chronic disease.
Our study population comprised 7000 diabetes patients 
in  a  large  medical  group  owned  by  a  health  plan. 
Improvement in care of patients with diabetes had been 
a priority of the medical group since about 1995 (8). In 
late 1999, medical group leaders decided to undertake a 
major intervention to increase the availability of appoint-
ments,  thus  increasing  patient  satisfaction;  overall  effi-
ciency; and, ultimately, plan membership. The advanced 
access  model  was  selected,  and  the  intervention  began 
in  2000.  Consultants  engaged  to  help  with  the  change 
conducted a series of 1- to 2-day workshops during 2000 
for improvement teams from all 17 of the group’s primary 
care  clinics.  Consultants  provided  training,  and  a  care 
improvement  team  provided  regular  measurement  and 
feedback of appointment availability to providers and clin-
ics. Advertisements in the media informed patients about 
the better availability of clinic appointments with their 
regular physicians. Elimination of more than 100 appoint-
ment types with different stipulations based on provider 
preferences and transformation to standardized appoint-
ment types enabled scheduling of most appointments for 
the same amount of time, regardless of visit reason. The 
intervention attempted to eliminate frozen slots (schedule 
holds [i.e., time on a provider’s regular work schedule not 
made available for scheduled patients and often used for 
paper work and phone calls]) and required physicians to 
work extra hours to see patients who already had been 
scheduled  for  future  appointments.  Because  patients 
received no systematic reminder calls for recommended 
follow-up  appointments  before  or  after advanced  access 
implementation, change in continuity measure could not 
be attributed to reminder mechanisms.
Methods
We conducted this study in a 550-physician multispe-
cialty medical group that has 17 primary care clinics and 
is owned by a health plan. The plan comprises 650,000 
members, of whom 240,000 are cared for by this medical 
group. We identified 7000 adult patients (older than 18 
years of age) with diabetes from health plan administra-
tive databases using algorithms modified from a previous-
ly described approach and validated against chart audits 
(9). Patients included in the study had to be enrolled in 
the plan for 11 of 12 months of each study year and to 
have two or more specific International Classification of 
Diseases, Ninth Revision, outpatient diabetes diagnostic 
codes, one inpatient diagnostic code, or a filled prescription 
for  diabetes-specific  medication  within  a  1-year  period. 
We excluded patients with gestational diabetes. We also 
excluded  patients  taking  metformin  alone  who  did  not 
have a diabetes code because chart audits indicated that 
providers used metformin to treat impaired glucose toler-
ance and polycystic ovary disease as well as to treat diabe-
tes. Chart audits demonstrated a positive predictive value 
of 0.97 for this diabetes identification method.
We identified patients who met these criteria for 1999 
through 2001, and included each patient in the analysis 
for each year he or she was identified as having diabetes. 
We analyzed serial cross-sections of patients with diabetes 
to assess whether systematic changes in access were relat-
ed to improvements in care for all patients with diabetes, 
not just those who were continuously enrolled.
We developed three composite measures of glucose and 
lipid control — process, good control, and excellent control 
— and assessed them each year for each patient. Process 
assessed whether each patient had two or more hemoglo-
bin A1c (HbA1c) tests and one or more fasting lipid profile 
tests during the calendar year. For patients with at least 
one HbA1c and one low-density lipoprotein (LDL) test in 
a calendar year, two yearly composite outcome measures 
were assessed: good diabetes control and excellent diabetes 
control. We defined good control as both HbA1c < 8% and 
LDL < 130 mg/dL and excellent control as both HbA1c < 
7% and LDL < 100 mg/dL.
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time  for  appointments  and  continuity  of  care  —  yearly 
for each patient. We measured wait time using the com-
monly accepted measure (10) of days to third next avail-
able appointment with a provider in the patient’s primary 
clinic  and  monitored  the  improvement  with advanced 
access implementation using existing administrative data 
collected at each clinic. We calculated continuity of care on 
the basis of visits by a patient to different providers during 
each year (11). The formula is [∑(visiti 2) − ∑visit]/[∑visit 
×(∑visit  −  1)]  (where  i  =  specific  providers),  yielding  a 
number ranging from 0 to 1 (where higher numbers indi-
cate more continuity of care with a single provider) (12).
We calculated age, sex, and known coronary artery dis-
ease (CAD) yearly for each patient and as covariates in the 
analysis. We included CAD as a covariate because of the 
differential lipid goals for patients with known CAD and 
because it is the most common cause of morbidity and mor-
tality for people with diabetes. We also included the mean 
number of outpatient, primary care, and urgent care visits 
by these patients in each of the three study years.
We used multilevel logistic regression to predict per-
formance for the three composite measures in 2000 and 
2001 relative to 1999, controlling for age, sex, and CAD. 
A second set of analyses predicted the composite mea-
sures from the continuous wait time and continuity mea-
sures separately, controlling for age, sex, CAD, and year. 
Finally, a third set of analyses predicted the composite 
measures from yearly measured provider access and con-
tinuity of care, controlling for age, sex, CAD, and year, 
so the relation between each component of the advanced 
access model used by this medical group and the compos-
ite measures could be estimated while controlling for the 
other. Approximate P values for fixed parameters were 
estimated from the parameter coefficients and their stan-
dard  errors.  A  three-level  (patient-year  within  patient 
within  provider)  model  was  specified  for  all  analyses 
so  the  analysis  included  multiple  yearly  observations 
per  person  and  controlled  for  the  multiple  correlated 
observations within patients (i.e., multiple observations 
per patient) and within providers (i.e., multiple patients 
within provider) structure.
The  HealthPartners  Institutional  Review  Board 
reviewed, approved in advance, and monitored all steps 
in  the  development  of  the  identification  system,  aggre-
gation of data, and data analysis. Because the analysis 
used aggregate de-identified claims data, the institutional 
review board did not require informed consent.
Results
During  the  baseline  year  (1999),  44.4%  of  diabetes 
patients had an HbA1c < 7%, and 29.8% had an LDL < 
100 mg/dL, improving to 52.7% and 38.7%, respectively, in 
2001 (Table 1). Both wait time and continuity significantly 
improved  during  the  study  period.  Process  improved  in 
2000 compared with 1999, and both good control and excel-
lent  control  improved  during  2000  and  2001  compared 
with 1999.
Continuity of care was significantly related to each of 
the three composite measures (Table 2). Higher continuity 
scores were associated with a higher predicted proportion 
of patients meeting each measure. Wait time was not sig-
nificantly related to any of the three measures.
Finally, the third set of analyses predicted the compos-
ite measures from a model that included wait time and 
continuity  simultaneously.  With  both  of  these advanced 
access characteristics in the model, greater continuity of 
care continued to predict a higher proportion of patients 
meeting the process (P < .001) and excellent control (P = 
.017) measures. Prediction for good control no longer was 
statistically significant. This final set of analyses demon-
strated that continuity rather than shorter wait time was 
associated with improvement in care.
Discussion
In our study, appointment availability increased and con-
tinuity of care improved after implementation of advanced 
access in a large patient population. However, only con-
tinuity of care was associated with improved care. Other 
benefits of improving continuity of care, which have been 
well documented, include more positive visit experiences 
by patients (13) and reduced use of resources — and thus 
reduced costs (14). A recent study using evidence from the 
Third National Health and Nutrition Examination Survey 
(NHANES) concluded that good glucose control is more 
likely among people with diabetes who regularly see their 
usual physician or health provider to manage their condi-
tion (15). Our study observations are consistent with pre-
vious studies of continuity of care for patients with chronic 
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diseases (16-18) and support the hypothesis that quality of 
diabetes care could be improved by improving continuity of 
care by primary care physicians.
Although advanced access is proposed to improve con-
tinuity of care, theoretically by reducing wait time to see 
a provider, we did not find a direct relation between wait 
time and improved care. Additional analyses showed that 
shorter  provider  wait  time  was  only  weakly  associated 
with  increased  continuity  of  care  (P  =  .02).  Therefore, 
gains in continuity of care should be attributed only cau-
tiously to advanced access.
Several other changes in the medical group’s care sys-
tem made just before implementation of advanced access 
to support the change also might have substantially affect-
ed continuity of care. First, payment of physicians changed 
from a fixed yearly salary to a productivity-based provider 
reimbursement, leading to a general increase in physician 
productivity. In addition, centralized scheduling (19) facili-
tated  standardized  appointment  types  and  scheduling 
efficiency (lower costs), which also could improve continu-
ity. Thus, our findings that suggest relations among these 
variables  (advanced  access,  wait  time,  and  continuity) 
might be more complex than generally believed and might 
suggest an important direction for future research.
Composite measures of process and quality reflect the 
importance of managing both risk for CAD and glucose 
control  in  patients  with  diabetes.  Although  individual 
measures  of  HbA1c  and  LDL  improved  after advanced 
access implementation, we analyzed composite measures 
of process and quality because they are considered more 
representative of overall change in the system of care and 
have become the recommended measurement for diabe-
tes in Minnesota (20). This methodology was highlighted 
recently in the Institute of Medicine report on national 
health  care  measurement  standards  (21).  The  results 
might  look  unimpressive,  but  small  improvements  in 
composite measurement represent simultaneous improve-
ments in multiple clinical domains and possibly gains in 
care quality.
When our model incorporated both wait time and conti-
nuity, continuity was linked to the composite measure of 
excellent control but not of good control. This discrepancy 
might be explained in part by the increasing importance 
of continuity of care as care goals become more ambitious 
and  presumably  more  difficult  for  patients  to  achieve. 
Recent national guidelines for diabetes have lowered the 
recommended levels of HbA1c and LDL beyond even the 
measures of excellent control used in this study (22,23), 
possibly increasing the importance of continuity of care.
Self-reported  continuity  of  care  is  strongly  associated 
with  higher  patient  satisfaction  (24).  Yearly  satisfac-
tion  surveys  of  a  sample  of  the  patients  in  our  study 
after advanced access implementation showed significant 
increases  —  from  36%  to  55%  —  in  patients  reporting 
being very satisfied. Although the manner in which care is 
delivered most likely influences satisfaction, satisfaction 
cannot be attributed directly to either decreased wait time 
or continuity of care.
Some  physicians  have  suggested  that  access  models 
best serve patients with acute problems at the expense 
of patients with chronic diseases (7,19). Implementation 
of advanced access in this medical group met with physi-
cian  resistance  because  physicians  were  encouraged  to 
discontinue ingrained scheduling practices, such as limits 
on the number of double bookings, longer appointments 
for patients with chronic diseases or complaints thought 
to require more visit time, and use of frozen slots as catch-
up time. Many physicians worked overtime to reduce the 
backlog of patients already scheduled well into the future. 
Physicians questioned how advanced access would affect 
quality of care (19). Our results show that diabetes care 
and patient satisfaction improved after successful imple-
mentation of advanced access in primary care in this medi-
cal group. Our study should temper criticism of advanced 
access  as  an  “acute  care  model”  and  provider  concerns 
about deleterious effects on patients with chronic disease. 
At the very least, shorter wait time for appointments did 
not negatively affect glucose and lipid control in patients 
with  diabetes.  Moreover,  if  the  approach  to  improving 
appointment availability strongly emphasizes improving 
both continuity of care and access time, the impact may 
be positive.
The results of our study are subject to several limita-
tions.  First,  because  this  study  was  conducted  at  one 
multiclinic medical group, our results might not be gen-
eralizable  to  other  settings,  particularly  if  the  baseline 
characteristics (appointment availability and continuity) 
differ substantially. Future studies of models to improve 
appointment  access  should  consider  the  specifics  of  the 
access model being evaluated (e.g., advanced access, open 
access); some models promote physician-level continuity of 
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a control group and might not have accounted for secular 
trends. NHANES data showed that glucose control rates 
(defined as the proportion of patients with HbA1c < 7%) 
declined from 1994 to 2000 (25). Therefore, secular trends 
over the study period are unlikely to explain the study 
results. Third, diabetes measures in the community where 
this study took place have been better than national mea-
sures (26) and could be attributed to multiple initiatives 
other  than advanced  access  implementation  alone.  We 
addressed the concern about historical trend by including 
year of observation in the regression models predicting the 
composite care measures from wait time and continuity of 
care; however, including year in these models also could 
have diminished the effect of wait time on diabetes care 
if no other strong historical trends accounted for change 
during the study period.
Despite these limitations, our quantitative study is the 
first to compare the effects of change in access and conti-
nuity of care on the quality of care for patients with dia-
betes. The type of advanced access program implemented 
in this medical group, which promoted both continuity of 
care and same-day access for appointments, resulted in 
improved glucose and lipid control in adults with diabetes. 
The results suggest that reduced wait time does not del-
eteriously affect diabetes care. The study also reinforces 
the  results  of  previous  studies  showing  an  association 
between improved continuity of primary care and better 
diabetes control.
Acknowledgments
This project was supported by grant #041868 from The 
Robert Wood Johnson Foundation through the Improving 
Chronic Illness Care Initiative.
Author Information
Corresponding  Author:  JoAnn  M.  Sperl-Hillen,  MD, 
HealthPartners  Research  Foundation,  PO  Box  1524, 
MS#21111R,  Minneapolis,  MN  55440-1524.  Telephone: 
952-967-5009.  E-mail:  JoAnn.M.SperlHillen@healthpart-
ners.com.
Author  Affiliations:  JoAnn  M.  Sperl-Hillen,  Leif  I. 
Solberg,  Mary  C.  Hroscikoski,  A.  Lauren  Crain,  Karen 
I.  Engebretson,  Patrick  J.  O’Connor,  HealthPartners 
Research Foundation, Minneapolis, Minnesota.
References
1.  Institute of Medicine, Committee on Quality of Health 
Care in America. Crossing the quality chasm: a new 
health system for the 21st century. Washington (DC): 
National Academies Press; 2001.
2.  Carlson B. Same-day appointments promise increased 
productivity. Manag Care 2002;11(12):43–4.
3.  O’Hare  CD,  Corlett  J.  The  outcomes  of  open-access 
scheduling. Fam Pract Manag 2004;11(2):35–8.
4.  Murray  M,  Berwick  DM.  Advanced  access:  reduc-
ing  waiting  and  delays  in  primary  care.  JAMA 
2003;289(8):1035–40.
5.  Murray M, Bodenheimer T, Rittenhouse D, Grumbach 
K.  Improving  timely  access  to  primary  care:  case 
studies  of  the  advanced  access  model.  JAMA 
2003;289(8):1042–6.
6.  Murray M, Tantau C. Redefining open access to pri-
mary care. Manag Care Q 1999;7(3):45–55.
7.  Solberg LI, Maciosek MV, Sperl-Hillen JM, Crain AL, 
Engebretson KI, Asplin BR, et al. Does improved access 
to care affect utilization and costs for patients with 
chronic conditions? Am J Manag Care 2004;10(10):717–
22.
8.  Sperl-Hillen  J,  O’Connor  PJ,  Carlson  RR,  Lawson 
TB, Halstenson C, Crowson T, et al. Improving dia-
betes care in a large health care system: an enhanced 
primary  care  approach.  Jt  Comm  J  Qual  Improv 
2000;26(11):615–22.
9.  Desai J, O’Connor PJ, Rush WA, Harris J, Bluhm J, 
Clark C, et al. Assessing the quality of diabetes care 
in  owned  and  contracted  HMO  clinic  populations 
[Poster]. CDC Diabetes Translation Conference San 
Diego, CA March 1997.
10. Bodenheimer  T,  Lorig  K,  Holman  H,  Grumbach  K. 
Patient  self-management  of  chronic  disease  in  pri-
mary care. JAMA 2002;288(19):2469–75.
11. Given  CW,  Branson  M,  Zemach  R.  Evaluation  and 
application  of  continuity  measures  in  primary  care 
settings. J Community Health 1985;10(1):22–41.
12. Pladevall  M,  Williams  LK,  Potts  LA,  Divine  G,  Xi 
H,  Lafata  JE.  Clinical  outcomes  and  adherence  to 
medications measured by claims data in patients with 
diabetes. Diabetes Care 2004;27(12):2800–5.
13. Nutting PA, Goodwin MA, Flocke SA, Zyzanski SJ, 
VOLUME 5: NO. 1
JANUARY 2008
  www.cdc.gov/pcd/issues/2008/jan/06_0177.htm • Centers for Disease Control and Prevention  5
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, 
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only 
and does not imply endorsement by any of the groups named above.VOLUME 5: NO. 1
JANUARY 2008
Stange KC. Continuity of primary care: to whom does 
it matter and when? Ann Fam Med 2003;1(3):149–55.
14. Raddish M, Horn SD, Sharkey PD. Continuity of care: 
is it cost effective? Am J Manag Care 1999;5(6):727–
34.
15. Mainous  AG  3rd,  Koopman  RJ,  Gill  JM,  Baker  R, 
Pearson WS. Relationship between continuity of care 
and diabetes control: evidence from the Third National 
Health  and  Nutrition  Examination  Survey.  Am  J 
Public Health 2004;94(1):66–70.
16. Wall  EM.  Continuity  of  care  and  family  medicine: 
definition, determinants, and relationship to outcome. 
J Fam Pract 1981;13(5):655–64.
17. Parchman  ML,  Pugh  JA,  Noel  PH,  Larme  AC. 
Continuity  of  care,  self-management  behaviors,  and 
glucose control in patients with type 2 diabetes. Med 
Care 2002;40(2):137–44.
18. Mainous AG 3rd, Gill JM. The importance of continu-
ity of care in the likelihood of future hospitalization: 
is site of care equivalent to a primary clinician? Am J 
Public Health 1998;88(10):1539–41.
19. Solberg LI, Hroscikoski MC, Sperl-Hillen JM, O’Connor 
PJ, Crabtree BF. Key issues in transforming health 
care organizations for quality: the case of advanced 
access. Jt Comm J Qual Saf 2004;30(1):15–24.
20. Measuring  health  care  quality.  St.  Paul  (MN):  MN 
Community Measurement. http://www.mnhealthcare.
org/~main.cfm. Accessed January 24, 2007.
21. Institute  of  Medicine,  Committee  on  Redesigning 
Health  Insurance  Performance  Measures,  Payment, 
and Performance Improvement Programs. Performance 
measures:  accelerating  improvement.  Pathways  to 
Quality Healthcare series. Washington (DC): National 
Academies Press; 2006.
22. American Diabetes Association. Clinical practice rec-
ommendations 2005. Diabetes Care 2005;28 Suppl 1:
S1–79.
23. AACE Diabetes Mellitus Clinical Practice Guidelines 
Task  Force.  American  Association  of  Clinical 
Endocrinologists medical guidelines for clinical prac-
tice for the management of diabetes mellitus. Endocr 
Pract 2007;13(Suppl 1):1-68.
24. Fan VS, Burman M, McDonell MB, Fihn SD. Continuity 
of care and other determinants of patient satisfaction 
with primary care. J Gen Intern Med 2005;20(3):226–
33.
25. Koro  CE,  Bowlin  SJ,  Bourgeois  N,  Fedder  DO. 
Glycemic control from 1988 to 2000 among U.S. adults 
diagnosed with type 2 diabetes: a preliminary report. 
Diabetes Care 2004;27(1):17–20.
26. Sperl-Hillen JM, O’Connor PJ. Factors driving diabe-
tes care improvement in a large medical group: ten 
years of progress. Am J Manag Care 2005;1 Suppl 2:
S177–85.
6  Centers for Disease Control and Prevention • www.cdc.gov/pcd/issues/2008/jan/06_0177.htm
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, 
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only 
and does not imply endorsement by any of the groups named above.Tables
Table 1. Characteristics of Patients With Diabetes Before (1999), During (2000), and After (2001) Implementation of 
Advanced Access Program, 1999–2001
Characteristic
1999 2000 2000 vs 1999 2001 2001 vs 1999
N = 6741 N = 7056 P N = 7238 P
Age in 1998, y 59.7 59.1 .01 58.1 < .001
Sex, % male 5.0% 5.2% .2 5.0% .19
Coronary artery disease 1.% 15.5% .06 15.6% .0
Wait time, da 21.6 11.0 < .001 .2 < .001
Continuity of carea,b .681 .699 .001 .725 < .001
≥ 2 HbA1c testsa .5% 66.0% .01 60.6% < .001
≥ 1 LDL testa 61.2% 68.7% < .001 67.9% < .001
HbA1c < 7%a .% 8.7% < .001 52.% < .001
HbA1c < 8%a 69.5% 7.5% < .001 76.5% < .001
LDL < 100 mg/dLa 29.8% 5.1% < .001 8.7% < .001
LDL < 10 mg/dLa 65.1% 69.6% < .001 71.8% < .001
Processa 6.9% 52.% < .001 8.8% .11
Good controla,c 8.7% 5.2% < .001 58.1% < .001
Excellent controla,d 1.6% 18.% < .001 21.8% < .001
No. of primary care visits .89 .56 < .001 .9 < .001
No. of diabetes-related primary care 
visits
2.7 2.7 < .001 2.50 < .001
≥ 1 Urgent care visit or emergency 
department visit
1.0% 0.1% .26 7.6% < .001
 
HbA1c indicates hemoglobin A1c; LDL, low-density lipoprotein. 
a Comparison controlled for age, sex, and coronary artery disease. 
b Continuity of care = proportion of visits with a single provider. 
c Good control defined as both HbA1c < 8% and LDL < 10 mg/dL. 
d Excellent control, as both HbA1c < 7% and LDL < 100 mg/dL.
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Table 2. Model-Based Predicted Proportion of Patients Meeting Three Measures of Glucose and Lipid Control According to 
Levels of Continuity of Care and Appointment Wait Time, Advanced Access Program, 1999–2001a
Measureb
Continuity Scorec
 P 0.25 0.50 0.75 1.0
Process 7. 8.0 8.8 9.6 .01
Good control 8.5 9. 0.1 0.9 .0
Excellent control .7 .9 .2 .5 < .001
Measureb
Wait Time Percentiled
 P  12.5 37.5 62.5 87.5
Process 6.8 6.7 6.6 6.2 .62
Good control 9.6 9.6 9.6 9.7 .95
Excellent control .2 .2 .2 .2 .98
 
a All values are percentages. 
b Multilevel logistic regression controlled for age, sex, coronary artery disease, and year. 
c A score ranging from 0 to 1, where high numbers indicate a greater proportion of visits with a single provider. 
d Length of wait in days until the next available appointment. A precise number of days´ wait depends on the setting (e.g., 5 days might be considered a 
short wait in some settings but long in others). For this reason, wait time divided into quartiles and expressed as the median percentile for each quartile 
(median of 0-25th percentile is 12.5). Wait time percentile should be interpreted such that a low percentile corresponds to less access (more days), where-
as a higher percentile corresponds to more access (fewer days).
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